Exacerbator subtypes in the tiotropium safety and performance in respimat (TIOSPIR™) trial
P. Calverley, D. Dusser, R. Wise, G. Pledger, R. Dahl, A. Mueller, J. Montero Caballero, A. Anzueto (Liverpool, United Kingdom; Sorbonne Paris Cité, Paris, France; Baltimore, Houston, San Antonio, United States Of America; Odense, Denmark; Ingelheim, Germany)
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Session: New clinical evidence for asthma and COPD treatments
Session type: Thematic Poster Session
Number: 2420
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Calverley, D. Dusser, R. Wise, G. Pledger, R. Dahl, A. Mueller, J. Montero Caballero, A. Anzueto (Liverpool, United Kingdom; Sorbonne Paris Cité, Paris, France; Baltimore, Houston, San Antonio, United States Of America; Odense, Denmark; Ingelheim, Germany). Exacerbator subtypes in the tiotropium safety and performance in respimat (TIOSPIR™) trial. Eur Respir J 2014; 44: Suppl. 58, 2420
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: